BioNTech SE

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioNTech SE and other ETFs, options, and stocks.

About BNTX

BioNTech SE operates as immunotherapy company, which engages therapies for cancer and other serious diseases. Its product pipeline include BNT162b2, BNT161, BNT164, FixVac, iNeST, RiboMabs, CAR-T Cells, TCRs and Next-Gen CP Immunomodulators.

CEO

Ugur Sahin

CEOUgur Sahin

Employees

6,772

Employees6,772

Headquarters

Mainz, Rheinland-Pfalz

HeadquartersMainz, Rheinland-Pfalz

Founded

2008

Founded2008

Employees

6,772

Employees6,772

BNTX Key Statistics

Market cap

25.37B

Market cap25.37B

Price-Earnings ratio

-66.61

Price-Earnings ratio-66.61

Dividend yield

—

Dividend yield—

Average volume

664.72K

Average volume664.72K

High today

$106.52

High today$106.52

Low today

$104.26

Low today$104.26

Open price

$104.55

Open price$104.55

Volume

528.19K

Volume528.19K

52 Week high

$129.27

52 Week high$129.27

52 Week low

$81.20

52 Week low$81.20

BNTX News

TipRanks 3d

BioNTech SE: Strategic AI Integration and Innovations Drive Buy Rating

Tazeen Ahmad, an analyst from Bank of America Securities, maintained the Buy rating on BioNTech SE. The associated price target remains the same with $134.00. E...

Nasdaq 3d

Why BioNTech Stock Jumped by Nearly 4% on Wednesday

Key Points The biotech continues to embrace artificial intelligence (AI) technology, which is heartening for investors. It owns and manages an AI developer, In...

TipRanks 3d

BioNTech Hosts Second AI Day to Showcase AI Integration

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

Analyst ratings

70%

of 23 ratings

Buy

69.6%

Hold

30.4%

Sell